First Time Loading...

DermTech Inc
NASDAQ:DMTK

Watchlist Manager
DermTech Inc Logo
DermTech Inc
NASDAQ:DMTK
Watchlist
Price: 0.6031 USD 3.02% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

DMTK Price Targets Summary
DermTech Inc

Wall Street analysts forecast DMTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMTK is 2.805 USD with a low forecast of 1.515 USD and a high forecast of 4.2 USD.

DMTK Lowest Forecast
Wall Street Target
1.515 USD
151% Upside
DMTK Average Forecast
Wall Street Target
2.805 USD
365% Upside
DMTK Highest Forecast
Wall Street Target
4.2 USD
596% Upside
Lowest
Price Target
1.515 USD
151% Upside
Average
Price Target
2.805 USD
365% Upside
Highest
Price Target
4.2 USD
596% Upside
DermTech Inc Competitors:
Price Targets
TSVT
2Seventy Bio Inc
164% Upside
DTIL
Precision BioSciences Inc
289% Upside
TRDA
Entrada Therapeutics Inc
72% Upside
MRSN
Mersana Therapeutics Inc
133% Upside
TSVT
2Seventy Bio Inc
164% Upside
DTIL
Precision BioSciences Inc
289% Upside
TRDA
Entrada Therapeutics Inc
72% Upside
MRSN
Mersana Therapeutics Inc
133% Upside
BVXP
Bioventix PLC
35% Upside
RNA
Avidity Biosciences Inc
96% Upside
I
TIL
Instil Bio Inc
166% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
9% Upside

Revenue
Forecast

Revenue Estimate
DermTech Inc

For the last 3 years the compound annual growth rate for DermTech Inc's revenue is 37%. The projected CAGR for the next 2 years is 20%.

37%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
DermTech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
DermTech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
DMTK intrinsic value, competitors valuation, and company profile.
DCF Valuation
DMTK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DMTK stock valuation using valuation multiples.
Wall Street Estimates
DMTK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DMTK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DMTK's stock price target?
Price Target
2.805 USD

According to Wall Street analysts, the average 1-year price target for DMTK is 2.805 USD with a low forecast of 1.515 USD and a high forecast of 4.2 USD.

What is DermTech Inc's Revenue forecast?
Projected CAGR
20%

For the last 3 years the compound annual growth rate for DermTech Inc's revenue is 37%. The projected CAGR for the next 2 years is 20%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.